Литература Aalkjaer C, Mulvany mj, Nyborg nc. Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries

Peptides. 2015;74:33-42.

Gutkowska J, Antunes-Rodrigues J, McCann SM. Atrial natriuretic peptide in brain and pituitary gland. Physiol Rev. 1997;77(2):465-515.

Gutkowska J, Jankowski M, Mukaddam-Daher S, McCann SM. Oxytocin is a cardiovascular hormone. Braz J Med Biol Res. 2000;33(6):625-633.

Gutkowska J, Jankowski M, Antunes-Rodrigues J. The role of oxytocin in cardiovascular regulation. Braz J Med Biol Res. 2014;47(3):206-214.

Haloui M, Arnal JF, Pham I, Gonzalez W, Lyoussi B, Michel JB. Functional compartmentation of the endocrine action of cardiac natriuretic peptides. Ann Endocrinol. 2000;61(1):32-40.

Hasegawa K, Fujiwara H, Doyama K, Miyamae M, Fujiwara T, Suga S, Mukoyama M, Nakao K, Imura H, Sasayama S. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation. 1993;88(2):372-380.

He WT, Mori M, Yu XF, Kanda T. Higher BNP levels within physiological range correlate with beneficial nonfasting lipid profiles in the elderly: a cross-sectional study. Lipids Health Dis. 2016;15(1):3.

Heinisch BB, Vila G, Resl M, Riedl M, Dieplinger B, Mueller T, Luger A, Pacini G, Clodi M. B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men. Diabetologia. 2012;55(5):1400-1405.

Herman JP, Dolgas CM, Rucker D, Langub MC. Localization of natriuretic peptide-activated guanylate cyclase mRNAs in the rat brain. J Comp Neurol. 1996;369(2):165-187.

Herring N, Zaman JA, Paterson DJ. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol Heart Circ Physiol. 2001;281(6):H2318-H2327.

Herrmann HC, Rosenthal AD, Davis CA. Cardiovascular effects of intracoronary atrial natriuretic peptide administration in man. Am Heart J. 1990;120(2):308-315.

Hirata Y, Ishii M, Sugimoto T, Matsuoka H, Sugimoto T, Kangawa K, Matsuo H. The effects of human atrial 28-amino acid peptide on systemic and renal hemodynamics in anesthetized rats. Circ Res. 1985;57(4):634-639.

Hirose M, Furukawa Y, Kurogouchi F, Nakajima K, Miyashita Y, Chiba S. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations. J Pharmacol Exp Ther. 1998;286(1):70-76.

Hobbs A, Foster P, Prescott C, Scotland R, Ahluwalia A. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation. 2004;110(10):1231-1235.

Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76(1):91-96.

Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA. 2002;99(10):7142-7147.

Holtz J, Stewart DJ, Elsner D, Bassenge E. In vivo atrial peptide-venodilation: minimal potency relative to nitroglycerin in dogs. Life Sci. 1986;39(23):2177-2184.

Horio T, Kohno M, Takeda T. Cosecretion of atrial and brain natriuretic peptides stimulated by endothelin-1 from cultured rat atrial and ventricular cardiocytes. Metabolism. 1993;42(1):94-96.

Horio T, Tokudome T, Maki T, Yoshihara F, Suga S, Nishikimi T, Kojima M, Kawano Y, Kangawa K. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology. 2003;144(6):2279-2284.

Huang H, John SW, Steinhelper ME. Organization of the mouse cardiac natriuretic peptide locus encoding BNP and ANP. J Mol Cell Cardiol. 1996;28(8):1823-1828.

Hughes AD, Nielsen H, Sever PS. The effect of atrial natriuretic peptide on human isolated resistance arteries. Br J Pharmacol. 1989;97(4):1027-1030.

Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab. 1994;78(6):1428-1435.

Hunt PJ, Espiner EA, Richards AM, Yandle TG, Frampton C, Nicholls MG. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Am J Physiol. 1995;269(6 Pt 2): R1397-R1403.

Hunt PJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. J Clin Endocrinol Metab. 1996;81(11):3871-3876.

Hutchinson HG, Trindade PT, Cunanan DB, Wu CF, Pratt RE. Mechanisms of natriuretic peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res. 1997;35(1):158-167.

Huxley VH, Tucker VL, Verburg KM, Freeman RH. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circ Res. 1987;60(2):304-307.

Ichiki T, Boerrigter G, Huntley BK, Sangaralingham SJ, McKie PM, Harty GJ, Harders GE, Burnett JC. Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R102-R109.

Ichiki T, Huntley BK, Sangaralingham SJ, Burnett JC. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides. JACC Heart Fail. 2015;3(9):715-723.

Igaki T, Itoh H, Suga SI, Hama N, Ogawa Y, Komatsu Y, Yamashita J, Doi K, Chun TH, Nakao K. Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Hypertens Res. 1998;21(1):7-13.

Ikeda M, Kohno M, Yasunari K, Yokokawa K, Horio T, Ueda M, Morisaki N, Yoshikawa J. Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17(4):731-736.

Imaizumi T, Takeshita A, Higashi H, Nakamura M. Аlpha-ANP alters reflex control of lumbar and renal sympathetic nerve activity and heart rate. Am J Physiol. 1987;253(5 Pt 2):H1136-H1140.

Imaizumi T, Takeshita A. Influence of ANP on sympathetic nerve activity and chronotropic regulation of the heart. J Cardiovasc Electrophysiol. 1993;4(6):719-729.

Indolfi C, Piscione F, Volpe M, Focaccio A, Lembo G, Trimarco B, Condorelli M, Chiariello M. Cardiac effects of atrial natriuretic peptide in subjects with normal left ventricular function. Am J Cardiol. 1989;63(5):353-357.

International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478(7367):103-109.

Ito S, Ohtsuki S, Katsukura Y, Funaki M, Koitabashi Y, Sugino A, Murata S, Terasaki T. Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier. J Cereb Blood Flow Metab. 2011;31(2):457-466.

Itoh H, Nakao K, Yamada T, Shirakami G, Kangawa K, Minamino N, Matsuo H, Imura H. Antidipsogenic action of a novel peptide, ‘brain natriuretic peptide’, in rats. Eur J Pharmacol. 1988;150(1-2):193-196.

Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990;86(5):1690-1697.

Itoh H, Pratt RE, Ohno M, Dzau VJ. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension. 1992;19(6 Pt 2):758-761.

Izumiya Y, Araki S, Usuku H, Rokutanda T, Hanatani S, Ogawa H. Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling. Int J Vasc Med. 2012.

Jacob M, Saller T, Chappell D, Rehm M, Welsch U, Becker BF. Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res Cardiol. 2013;108(3):347.

John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 1995;267(5198):679-681.

Jouvert P, Revel MO, Lazaris A, Aunis D, Langley K, Zwiller J. Activation of the cGMP pathway in dopaminergic structures reduces cocaine-induced EGR-1 expression and locomotor activity. J Neurosci. 2004;24(47):10716-19725.

Kairuz EM, Barber MN, Anderson CR, Kanagasundaram M, Drummond GR, Woods RL. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo. Cardiovasc Res. 2005;66(3):574-582.

Kalra PR, Clague JR, Bolger AP, Anker SD, Poole-Wilson PA, Struthers AD, Coats AJ. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation. 2003;107(4):571-573.

Kaneko T, Shirakami G, Nakao K, Nagata I, Nakagawa O, Hama N, Suga S, Miyamoto S, Kubo H, Hirai O. C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. Brain Res. 1993;612(1-2):104-109.

Karaahmet T, Tigen K, Dundar C, Pala S, Guler A, Kilicgedik A, Cevik C, Mahmutyazicioglu K, Isiklar I, Basaran Y. The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy. Echocardiography. 2010;27(8):954-960.

Kasama S, Furuya M, Toyama T, Ichikawa S. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Eur Heart J. 2008;29 (12):1485-1494.

Katsuura G, Nakamura M, Inouye K, Kono M, Nakao K, Imura H. Regulatory role of atrial natriuretic polypeptide in water drinking in rats. Eur J Pharmacol. 1986;121(2):285-287.

Kerkelä R, Ulvila J, Magga J. Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events. J Am Heart Assoc. 2015;4(10):e002423.

Kim SH, Han JH, Lim SH, Lee SJ, Kim SZ, Cho KW. Attenuation of inhibitory effect of CNP on the secretion of ANP from hypertrophied atria. Am J Physiol Regul Integr Comp Physiol. 2001;281(5):R1456-R1463.

Kisch B. Electron microscopy of the atrium of the heart. I. Guinea pig. Exp Med Surg. 1956;14(2-3):99-112.

Kishimoto I, Dubois SK, Garbers DL. The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA. 1996;93(12):6215-6219.

Kishimoto I, Tokudome T, Horio T, Soeki T, Chusho H, Nakao K, Kangawa K. C-type natriuretic peptide is a Schwann cell-derived factor for development and function of sensory neurones. J Neuroendocrinol. 2008;20(11):1213-1223.

Klinger JR, Warburton RR, Pietras L, Hill NS. Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats. J Appl Physiol. 1998;84(5):1646-1652.

Kohno M, Horio T, Yasunari K, Yokokawa K, Ikeda M, Kurihara N, Nishizawa Y, Morii H, Takeda T. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism. 1993;42(8):1059-1064.

Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Ueda M, Yoshikawa J. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ Res. 1997;81(4):585-590.

Kojima I, Kojima K, Rasmussen H. Role of calcium fluxes in the sustained phase of angiotensin II-mediated aldosterone secretion from adrenal glomerulosa cells. J Biol Chem. 1985;260(16):977-984.

Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation. 1992;86(4):1081-1088.

Kuhn M, Völker K, Schwarz K, Carbajo-Lozoya J, Flögel U, Jacoby C, Stypmann J, van Eickels M, Gambaryan S, Hartmann M, Werner M, Wieland T, Schrader J, Baba HA. The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice. J Clin Invest. 2009;119(7):2019-2030.

Kuhn M. Endothelial actions of atrial and B-type natriuretic peptides. Br J Pharmacol. 2012;166(2):522-531.

Kun A, Kiraly I, Pataricza J, Marton Z, Krassoi I, Varro A, Simonsen U, Papp JG, Pajor L. C-type natriuretic peptide hyperpolarizes and relaxes human penile resistance arteries. J Sex Med. 2008;5(5):1114-1125.

Kuo JY, Yeh HI, Chang SH, Shih BF, Wang AM, Chen CY, Hou CJ. C-type natriuretic peptide in individuals with normal left ventricular systolic function. Scand Cardiovasc J. 2007;41(3):155-159.

Kuroskide Bold ML, de Bold AJ. Stretch-secretion coupling in atrial cardiocytes. Dissociation between atrial natriuretic factor release and mechanical activity. Hypertension. 1991;18(5 Suppl):III169-III178.

Kyriakides ZS, Sbarouni E, Antoniadis A, Iliodromitis EK, Mitropoulos D, Kremastinos DT. Atrial natriuretic peptide augments coronary collateral blood flow: a study during coronary angioplasty. Clin Cardiol. 1998;21(10):737-742.

Langub MC, Dolgas CM, Watson RE, Herman JP. The C-type natriuretic peptide receptor is the predominant natriuretic peptide receptor mRNA expressed in rat hypothalamus. J Neuroendocrinol. 1995;7(4):305-309.

Langub MC, Watson RE, Herman JP. Distribution of natriuretic peptide precursor mRNAs in the rat brain. J Comp Neurol. 1995;356(2):183-199.

Lapiński M, Stepniakowski K, Januszewicz A, Noszczyk B, Szczepańska-Sadowska E. Atrial natriuretic factor enhances vasopressin-induced bradycardia in normotensive (WKY) but not in spontaneously hypertensive (SHR) rats. Eur J Clin Invest. 1988;18(6):568-574.

LaPointe MC, Wu G, Garami M, Yang XP, Gardner DG. Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes. Hypertension. 1996;27(3 Pt 2):715-722.

Laxson DD, Dai XZ, Schwartz JS, Bache RJ. Effects of atrial natriuretic peptide on coronary vascular resistance in the intact awake dog. J Am Coll Cardiol. 1988;11(3):624-629.

Lazo M, Young JH, Brancati FL, Coresh J, Whelton S, Ndumele CE, Hoogeveen R, Ballantyne CM, Selvin E. NH2-terminal pro-brain natriuretic peptide and risk of diabetes. Diabetes. 2013;62(9):3189-3193.

Lee CY, Lieu H, Burnett JC. Designer natriuretic peptides. J Investig Med. 2009;57(1):18-21.

Lee DH, Youn HJ, Choi YS, Lee JM, Park CS, Jung HO, Jeon HK, Lee MY. C-type natriuretic Peptide as a surrogate marker in variant angina pectoris. Korean Circ J. 2013;43(3):168-173.

Lee S, Park SK, Kang KP, Kang SK, Kim SZ, Kim W. Relationship of plasma Dendroaspis natriuretic peptide-like immunoreactivity and echocardiographic parameters in chronic haemodialysis patients. Nephrology. 2004;9(3):171-175.

Leskinen H, Vuolteenaho O, Ruskoaho H. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release. Circ Res. 1997;80(1):114-123.

Levin ER, Frank HJ. Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor. Am J Physiol. 1991;261(2 Pt 2):R453-R457.

Levin ER, Gardner DG, Samson WK. Natriuretic Peptides. N Engl J Med. 1998;339(95):321-328.

Levy FO. Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility. Naunyn Schmiedebergs Arch Pharmacol. 2013;386(8):665-670.

Lewko B, Endlich N, Kriz W, Stepinski J, Endlich K. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress. Kidney Int. 2004;66(3):1001-1008.

Li D, Lu CJ, Hao G, Wright H, Woodward L, Liu K, Vergari E, Surdo NC, Herring N, Zaccolo M, Paterson DJ. Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons. Hypertension. 2015;66(1):190-198.

Li ZQ, Liu YL, Li G, Li B, Liu Y, Li XF, Liu AJ. Inhibitory effects of C-type natriuretic peptide on the differentiation of cardiac fibroblasts, and secretion of monocyte chemoattractant protein-1 and plasminogen activator inhibitor-1. Mol Med Rep. 2015;11(1):159-165.

Light DB, Schwiebert EM, Karlson KH, Stanton BA. Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science. 1989;243(4889):383-385.

Lipari A, Farina E, Gerbino A, Lipari L. Atrial natriuretic peptide (ANP) and oxytocin-expression in the adult rat and mouse cerebellum. Cerebellum Ataxias. 2015;2:12.eCollection 2015.

Ljutić D, Rumboldt Z. The influence of the atrial natriuretic factor on venous tone in man. Int J Clin Pharmacol Res. 1989;9(4):255-260.

Loewi O. Übertragbarkeit der Herznervenwirkung. Pflugers Arch Gesamte Physiol. 1921;189:239-242.

Luchner A, Muders F, Dietl O, Friedrich E, Blumberg F, Protter AA, Riegger GA, Elsner D. Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovasc Res. 2001;51(3):601-607.

Lumsden NG, Khambata RS, Hobbs AJ. C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr Pharm Des. 2010;16(37):4080-4088.

MacKay MJ, Cheung DW. Inhibition of neuromuscular transmission in the guinea-pig saphenous artery by atriopeptin II. Can J Physiol Pharmacol. 1987;65(9):1988-1990.

Maeder MT, Mariani JA, Kaye DM. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress. Hypertension. 2010;6(4):682-689.

Magnusson M, Jujic A, Hedblad B, Engström G, Persson M, Struck J, Morgenthaler NG, Nilsson P, Newton-Cheh C, Wang TJ, Melander O. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. J Clin Endocrinol Metab. 2012;97(2):638-645.

Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC Jr. Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics. Eur Heart J. 2013;34(12):886-893.

Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature. 1986;324(6096):473-476.

Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, Smithies O. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA. 1999;96(13):7403-7408.

McKenzie JC, Berman NE, Thomas CR, Young JK, Compton LY, Cothran LN, Liu WL, Klein RM. Atrial natriuretic peptide-like (ANP-LIR) and ANP prohormone immunoreactive astrocytes and neurons of human cerebral cortex. Glia. 1994;12(3):228-243.

Melo LG, Veress AT, Ackermann U, Steinhelper ME, Pang SC, Tse Y, Sonnenberg H. Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: role of cardiovascular sympathetic tone. Cardiovasc Res. 1999;43(2):437-444.

Mendelsohn FA, Allen AM, Chai SY, Sexton PM, Figdor R. Overlapping distributions of receptors for atrial natriuretic peptide and angiotensin II visualized by in vitro autoradiography: morphological basis of physiological antagonism. Can J Physiol Pharmacol. 1987;65(8):1517-1521.

Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, Yamahara K, Taura D, Inuzuka M, Sonoyama T, Nakao K. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes. 2009;58(12):2880-2892.

Mizuno O, Onishi K, Dohi K, Motoyasu M, Okinaka T, Ito M, Isaka N, Nakano T. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure. Am J Cardiol. 2001;88(8):863-866.

Moalem J, Davidov T, Zhang Q, Grover GJ, Weiss HR, Scholz PM. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production. J Surg Res. 2006;135(1) 38-44. doi: 10.1016/j.jss.2006.01.012

Moltzau LR, Aronsen JM, Meier S, Skogestad J, Orstavik O, Lothe GB, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Qvigstad E. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle. J Pharmacol Exp Ther. 2014;350(3):681-690. doi: 10.1124/jpet.114.214882

Mori Y, Nishikawa M, Matsubara H, Toyoda N, Masaki H, Yonemoto T, Takagi T, Inada M. Regulation of atrial natriuretic hormone production by triiodothyronine in cultured rat atrial myocytes. Acta Endocrinol (Copenh). 1991;125(6):694-899.

Moro C, Crampes F, Sengenes C, De Glisezinski I, Galitzky J, Thalamas C, Lafontan M, Berlan M. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J. 2004;18(7):908-910. doi: 10.1096/fj.03-1086fje

Moro C, Pillard F, de Glisezinski I, Klimcakova E, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M. Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men. Am J Physiol Endocrinol Metab. 2008;295(2):E505-E513. doi: 10.1152/ajpendo.90227.2008

Moro C, Lafontan M. Natriuretic peptides and cGMP signaling control of energy homeostasis. Am J Physiol Heart Circ Physiol. 2013;304(3):H358-H368. doi: 10.1152/ajpheart.00704.2012

Moyes AJ, Khambata RS, Villar I, Bubb KJ, Baliga RS, Lumsden NG, Xiao F, Gane PJ, Rebstock AS, Worthington RJ, Simone MI, Mota F, Rivilla F, Vallejo S, Peiró C, Sánchez Ferrer CF, Djordjevic S, Caulfield MJ, MacAllister RJ, Selwood DL, Ahluwalia A, Hobbs AJ. Endothelial C-type natriuretic peptide maintains vascular homeostasis. J Clin Invest. 2014;124(9):4039-4051. doi: 10.1172/JCI74281

Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87(4):1402-1412. doi: 10.1172/JCI115146

Mulvany MJ, Nyborg NC. Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries. Br J Pharmacol. 1985;86(2):447-453.

Мурашов А.Н., Давыдова С.А., Степанова Т.В., Беспалова Ж.В., Медведев О.С. Барорефлекторный компонент в механизме гипотензивного действия предсердных пептидов.